We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04887831
Brief Title: Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab (PRESERVE3)

First Submitted : May 5, 2021
First Submitted that Met QC Criteria : May 13, 2021
First Posted : May 14, 2021

Last Update Submitted that Met QC Criteria : January 24, 2023
Last Update Posted : January 26, 2023